ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÅÓñçù£©ÒÈÏÙ°©Ö÷ÒªÊÇÒÈÏÙµ¼¹ÜÏÙ°© (PDAC)£¬£¬£¬ÊÇÒ»ÖÖÔ¤ºó¼«²îµÄÏû»¯µÀÖ×Áö£¬£¬£¬±»³ÆÎª°©Íõ£¬£¬£¬¾ßÓжñÐԳ̶ȸߡ¢Ï£Íû¿ì£¬£¬£¬·¢²¡ÒþÄä¡¢×ªÒÆÔ磬£¬£¬Ô¤ºó²îµÄÌØµã£¬£¬£¬ÏÖÔÚÉÐÎ޽ϺõÄÖÎÁÆÊֶΣ¬£¬£¬Ø½ÐèÑо¿¿ªÕ¹ÐµÄÖÎÁÆÕ½ÂÔ/Ò©Îï¡£¡£ÒÈÏÙ°©¸Éϸ°ûÊǹ«ÈϵÄÒÈÏÙ°©ÄÍÒ©ºÍ¸´·¢×ªÒƵÄÖ÷ÒªÓÕÒò¡£¡£Òò´Ë£¬£¬£¬°ÐÏòÖ×Áö¸Éϸ°û²¢¼ÓÒÔɨ³ýÊÇսʤÒÈÏÙ°©»¯ÁÆÄÍÒ©²¢·ÀÖ¹°©Ö¢¸´·¢×ªÒƵÄÒªº¦¡£¡£µ«Æù½ñΪֹ£¬£¬£¬ÁÙ´²ÉÏÉÐδÓÐÄÜÓÐÓÃÕë¶ÔÒÈÏÙ°©Ö×Áö¸Éϸ°ûµÄÒ©Îï¡£¡£
2024Äê3Ô£¬£¬£¬ÖÐɽҽѧԺÖÜÐËÍú½ÌÊÚÍŶÓÔÚÖпÆÔº1ÇøµÄPhytomedicineÔÓÖ¾ÕýʽÔÚÏß½ÒÏþÁËÌâΪA novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancerµÄÑо¿ÂÛÎÄ£¬£¬£¬·¢Ã÷ÖÐÒ©ÎâÜïÝÇȪԴµÄÉúÎï¼îÒòËØDeHE(Dehydroevodiamine)ÔÚÌåÄÚÍâ¾ù¿ÉÒÖÖÆÒÈÏÙ°©µÄÉú³¤ÔöÖ³£¬£¬£¬ÌØÊâÊÇÆäÓÐÓÃÒÖÖÆÒÈÏÙ°©Ö×Áö¸Éϸ°ûµÄÐγɺÍÖ×Áöϸ°û¸ÉÐÔ£¬£¬£¬²¢Õ¹ÏÖÆä×÷ÓõķÖ×Ó»úÖÆÊÇͨ¹ý°ÐÏò¼¤»î°ûÄÚµÄDDIT3 (ÄÚÖÊÍøÓ¦¼¤ÂѰ×)°Ðµã£¬£¬£¬µ÷¿ØÏÂÓεÄDDIT3/TRIB3/AKT/mTORÐźÅͨ·¡£¡£
¸ÃÑо¿Ê¹ÓÃÈËÀàµÄPANC-1ÒÈÏÙ°©Ï¸°ûÒìÖÖÒÆÖ²Ð¡ÊóÄ£×Ó·¢Ã÷£º£º£ºDeHEÒÖÖÆÒÈÏÙ°©Ö×ÁöÉú³¤µÄ¿¹°©»îÐÔÂÔÓÅÓÚÏÖÓеÄÁÙ´²Ò»Ïß¿¹ÒÈÏÙ°©Ò©ÎJÎ÷Ëû±õ£¬£¬£¬ÇÒ¾ßÓÐÓÅÒìµÄÖÎÁÆÇå¾²ÐÔ¡£¡£¸üΪÖ÷ÒªµÄÊÇ£¬£¬£¬ÒÔÒÈÏÙ°©Ï¸°ûµÄÌØÓиÉÐÔ±ê¼Ç·Ö×Ó×÷Ϊ¼ì²âÖ¸±ê£¬£¬£¬Á÷ʽϸ°ûʵÑéÅú×¢DeHE¿ÉÏÔÖøÒÖÖÆÒÈÏÙ°©¸Éϸ°ûµÄÐγɺÍÖ×Áöϸ°û¸ÉÐÔ£¨ÑôÐÔ±ÈÕÕÒ©¼ªÎ÷Ëû±õÔòÏà·´£©¡£¡£»£»ùÒò±í´ïÆ×ÆÊÎö·¢Ã÷DeHE¶ÔÖ×Áöϸ°û¸ÉÐԵĵ÷¿ØÓë°ÐÏò¼¤»î°ûÄÚµÄDDIT3·Ö×ÓÓйأ¬£¬£¬ÇÒ¸ÃÒ©Îï-ÂѰװбêµÄÏ໥×÷ÓûñµÃÒ©ÎïÇ׺ÍÁ¦·´Ó³°Ð±êÎȹÌÐÔʵÑé (DARTS)ºÍ·Ö×Ó¶Ô½ÓµÄÑéÖ¤¡£¡£Ê¹ÓÃsiDDIT3ºÍÌØÒìÒÖÖÆ¼ÁÌåÄÚÍâ¸ÉÔ¤DDIT3°Ðµã¼°ÆäÏÂÓÎÐźÅͨ·£¬£¬£¬DeHEÒÖÖÆÒÈÏÙ°©Ï¸°ûÔöÖ³ºÍÖ×Áöϸ°û¸ÉÐԵĹ¦Ð§¿É»ñµÃ²¿·Ö»Ø¸´¡£¡£
×ÛÉÏËùÊö£¬£¬£¬DeHE¾ßÓпªÕ¹Îª°ÐÏòÖ×Áö¸Éϸ°ûÖÎÁÆÒÈÏÙ°©µÄÐÂÐÍÒ©ÎïµÄDZÁ¦¡£¡£

¸ÃÏîÑо¿ÔÚngµç×ÓÓÎÏ·ÖÐɽҽѧԺÖÜÐËÍú½ÌÊÚÉè¼ÆºÍÖ¸µ¼ÏÂÍê³É£¬£¬£¬ÖÜÐËÍúΪ±¾ÂÛÎĵÄ×îºóͨѶ×÷Õß¡£¡£ÖÐɽҽѧԺÑо¿ÉúÖìËØÀöΪÂÛÎĵÚÒ»×÷Õߣ¬£¬£¬²¢»ñµÃôßÄÏ´óѧµËÀö¾ê²©Ê¿ºÍÆëÃ÷²©Ê¿µÈÅäºÏÊðÃû×÷ÕßµÄ×ÊÖú¡£¡£Ñо¿»ñµÃ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðµÄÖ§³Ö¡£¡£
ÔÎÄÁ´½Ó£º£º£ºhttps://authors.elsevier.com/a/1inFA3MpM%7EuU2e